Prognostic indicators of survival in ALS
Year: 1998
Type: article
Source: Neurology
DOI: 10.1212/wnl.50.1.66
Authors: Nancy Stambler, Matthew Charatan, Jesse M. Cedarbaum, ALS CNTF Treatment Study Group*
Institution: Regeneron (United States)
Language: Dutch
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Regeneron Pharmaceuticals
OpenAlex ID: W2130462384
